Nifty, BSE Sensex to Open Higher on Vaccine News

Published 10-11-2020, 08:35 am
Updated 10-11-2020, 08:37 am
UK100
-
DJI
-
JP225
-
ASX
-
PFE
-
IND50
-
NSEI
-
KS11
-
BSESN
-

By Aditya Raghunath

Investing.com -- Just as it seemed that the markets would consolidate on November 10 after six consecutive sessions of rallies, pharma giant Pfizer (NYSE:PFE) announced that its experimental COVID-19 vaccines tested more than 90% effective. Dow Jones shot up by almost 3% overnight on this news, which means investors can expect Nifty and BSE Sensex to rally strongly today. Nifty Futures are trading up by more than 1% at around 8:45 am.

Pfizer along with its German partner BioNTech has developed the vaccine. They are the first pharmaceutical companies that have released large-scale data from clinical trials of a coronavirus vaccine. The duo has said that they have not found any serious safety issues and will be seeking US approval in November itself to roll out the vaccine for emergency use.

Even though initial trials look promising, it’ll be quite sometime before the vaccine reaches Indian shores. Pfizer says that it can produce up to 50 million doses in 2020 and 1.2 billion doses in 2021. These vaccine doses can only be manufactured after the vaccine is approved.

European stocks ended up at eight-month highs after the vaccine news gave a boost to the rally that was already going on after Joe Biden was announced as the President-elect of the USA. The FTSE gained 4.67%, CAC was up 7.57% and the DAC ended 4.94% higher. Japan’s Nikkei 225 is trading 1.31% higher in early trade. Australia’s ASX Ltd (ASX:ASX) 200 was up 1.54%. South Korea’s KOSPI was also up 0.22% after dropping early.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.